Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 367 | 342 | 522 | 574 | 3,258 |
| Cost of Goods | 286 | 165 | 220 | 277 | 1,433 |
| Gross Profit | 82 | 177 | 302 | 297 | 1,825 |
| Operating Expenses | 760 | 419 | 535 | 802 | 1,527 |
| Operating Income | -392 | -77 | -13 | -228 | 731 |
| Interest Expense | 77 | 36 | 50 | 33 | 0 |
| Other Income | 72 | 0 | 4 | -1 | -80 |
| Pre-tax Income | -397 | -113 | -59 | -263 | 651 |
| Net Income Continuous | -397 | -113 | -59 | -263 | 651 |
| Net Income | $-397 | $-113 | $-59 | $-263 | $651 |
| EPS Basic Total Ops | 298.51 | -59.70 | -59.70 | -179.10 | -119.40 |
| EPS Basic Continuous Ops | 143.61 | -67.11 | -35.15 | -156.36 | -207.93 |
| EPS Diluted Total Ops | 298.51 | -59.70 | -59.70 | -179.10 | -119.40 |
| EPS Diluted Continuous Ops | 143.61 | -67.11 | -35.15 | -156.36 | -207.93 |
| EBITDA(a) | $-296 | $-58 | $5 | $-178 | $771 |